These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 7941607

  • 1. [Therapy of tuberculosis].
    Eier A, Grass S.
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of tuberculosis].
    Dautzenberg B.
    Rev Prat; 1996 Jun 01; 46(11):1350-5. PubMed ID: 8794618
    [Abstract] [Full Text] [Related]

  • 4. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S, Frei R, Reusser P.
    Schweiz Med Wochenschr; 1998 Feb 14; 128(7):264-7. PubMed ID: 9540152
    [Abstract] [Full Text] [Related]

  • 5. Principles of therapy for tuberculosis.
    Ortona L, Antinori A.
    Rays; 1998 Feb 14; 23(1):181-92. PubMed ID: 9673144
    [Abstract] [Full Text] [Related]

  • 6. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.
    Int J Tuberc Lung Dis; 2000 Feb 14; 4(2):108-14. PubMed ID: 10694087
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Jun 14; 3(6):466-70. PubMed ID: 10383057
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA, Andreevskaia SN, Smirnova TG, Chernousova LI, Chukanov VI.
    Probl Tuberk Bolezn Legk; 2004 Jun 14; (8):25-8. PubMed ID: 15478554
    [Abstract] [Full Text] [Related]

  • 12. Drug-resistant Mycobacterium tuberculosis in California, 1991 to 1992.
    Koo D, Royce S, Rutherford GW.
    West J Med; 1995 Nov 14; 163(5):441-5. PubMed ID: 8533406
    [Abstract] [Full Text] [Related]

  • 13. [Anti-tuberculosis chemotherapy].
    Wada M.
    Kekkaku; 2007 Oct 14; 82(10):771-81. PubMed ID: 18018601
    [Abstract] [Full Text] [Related]

  • 14. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N.
    Kekkaku; 2001 Dec 14; 76(12):723-8. PubMed ID: 11806128
    [Abstract] [Full Text] [Related]

  • 15. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 14; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 16. Tuberculosis treatment: dangerous regimens?
    Rieder HL, Arnadottir T, Trébucq A, Enarson DA.
    Int J Tuberc Lung Dis; 2001 Jan 14; 5(1):1-3. PubMed ID: 11263509
    [No Abstract] [Full Text] [Related]

  • 17. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb 14; 30(2):179-83. PubMed ID: 19565883
    [Abstract] [Full Text] [Related]

  • 18. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul 14; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

  • 19. Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?
    Bastian I, Rigouts L, Van Deun A, Portaels F.
    Bull World Health Organ; 2000 Jul 14; 78(2):238-51. PubMed ID: 10743297
    [Abstract] [Full Text] [Related]

  • 20. [Incidence of resistance and risk factors for resistance in Mycobacterium tuberculosis. A retrospective study of 1,055 patients of a specialty hospital 1984 to 1993].
    Borchardt J, Kirsten D, Jörres R, Kroeger C, Magnussen H.
    Pneumologie; 1996 Jan 14; 50(1):28-35. PubMed ID: 8774932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.